VERA BRADLEY INC (VRA) Fundamental Analysis & Valuation

NASDAQ:VRA • US92335C1062

Current stock price

3.94 USD
-0.05 (-1.25%)
At close:
3.94 USD
0 (0%)
After Hours:

This VRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VRA Profitability Analysis

1.1 Basic Checks

  • VRA had negative earnings in the past year.
  • VRA had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: VRA reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: VRA reported negative operating cash flow in multiple years.
VRA Yearly Net Income VS EBIT VS OCF VS FCFVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

  • The Return On Assets of VRA (-20.44%) is worse than 91.11% of its industry peers.
  • The Return On Equity of VRA (-36.34%) is worse than 84.44% of its industry peers.
Industry RankSector Rank
ROA -20.44%
ROE -36.34%
ROIC N/A
ROA(3y)-12.89%
ROA(5y)-10%
ROE(3y)-22.69%
ROE(5y)-17.28%
ROIC(3y)N/A
ROIC(5y)N/A
VRA Yearly ROA, ROE, ROICVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 -10 -20 -30

1.3 Margins

  • VRA has a Gross Margin of 46.37%. This is comparable to the rest of the industry: VRA outperforms 42.22% of its industry peers.
  • VRA's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for VRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5Y-3.94%
VRA Yearly Profit, Operating, Gross MarginsVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. VRA Health Analysis

2.1 Basic Checks

  • VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VRA has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, VRA has less shares outstanding
  • There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VRA Yearly Shares OutstandingVRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
VRA Yearly Total Debt VS Total AssetsVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 2.75 indicates that VRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • VRA has a Altman-Z score (2.75) which is in line with its industry peers.
  • VRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.75
ROIC/WACCN/A
WACC11.08%
VRA Yearly LT Debt VS Equity VS FCFVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.37 indicates that VRA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.37, VRA is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • VRA has a Quick Ratio of 2.37. This is a bad value and indicates that VRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VRA has a Quick ratio of 0.87. This is in the lower half of the industry: VRA underperforms 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 0.87
VRA Yearly Current Assets VS Current LiabilitesVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. VRA Growth Analysis

3.1 Past

  • VRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.23%, which is quite good.
  • VRA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.51%.
  • Measured over the past years, VRA shows a very negative growth in Revenue. The Revenue has been decreasing by -10.45% on average per year.
EPS 1Y (TTM)9.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130%
Revenue 1Y (TTM)-27.51%
Revenue growth 3Y-18.6%
Revenue growth 5Y-10.45%
Sales Q2Q%-15.08%

3.2 Future

  • VRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.03% yearly.
  • The Revenue is expected to grow by 1.01% on average over the next years.
EPS Next Y41.8%
EPS Next 2Y42.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.45%
Revenue Next 2Y1.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VRA Yearly Revenue VS EstimatesVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
VRA Yearly EPS VS EstimatesVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. VRA Valuation Analysis

4.1 Price/Earnings Ratio

  • VRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VRA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VRA Price Earnings VS Forward Price EarningsVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRA Per share dataVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VRA's earnings are expected to grow with 42.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.03%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VRA Dividend Analysis

5.1 Amount

  • No dividends for VRA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VRA Fundamentals: All Metrics, Ratios and Statistics

VERA BRADLEY INC

NASDAQ:VRA (4/24/2026, 8:13:34 PM)

After market: 3.94 0 (0%)

3.94

-0.05 (-1.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-12
Earnings (Next)06-09
Inst Owners34.77%
Inst Owner Change0%
Ins Owners15.49%
Ins Owner Change17.93%
Market Cap110.20M
Revenue(TTM)269.65M
Net Income(TTM)-47.84M
Analysts45
Price Target5.61 (42.39%)
Short Float %6.19%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)310.53%
Min EPS beat(2)-170.03%
Max EPS beat(2)791.09%
EPS beat(4)2
Avg EPS beat(4)127.71%
Min EPS beat(4)-197.03%
Max EPS beat(4)791.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.67%
Min Revenue beat(2)-0.08%
Max Revenue beat(2)5.42%
Revenue beat(4)1
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-10.65%
Max Revenue beat(4)5.42%
Revenue beat(8)1
Avg Revenue beat(8)-7.24%
Revenue beat(12)1
Avg Revenue beat(12)-6.48%
Revenue beat(16)3
Avg Revenue beat(16)-5.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-780%
EPS NY rev (3m)-780%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 0.84
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS9.64
BVpS4.71
TBVpS4.71
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -20.44%
ROE -36.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.37%
FCFM N/A
ROA(3y)-12.89%
ROA(5y)-10%
ROE(3y)-22.69%
ROE(5y)-17.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5Y-3.94%
F-Score2
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.37%
Cap/Sales 1.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 0.87
Altman-Z 2.75
F-Score2
WACC11.08%
ROIC/WACCN/A
Cap/Depr(3y)60.71%
Cap/Depr(5y)58.74%
Cap/Sales(3y)1.82%
Cap/Sales(5y)1.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130%
EPS Next Y41.8%
EPS Next 2Y42.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.51%
Revenue growth 3Y-18.6%
Revenue growth 5Y-10.45%
Sales Q2Q%-15.08%
Revenue Next Year-0.45%
Revenue Next 2Y1.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.29%
OCF growth 3YN/A
OCF growth 5YN/A

VERA BRADLEY INC / VRA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VERA BRADLEY INC?

ChartMill assigns a fundamental rating of 3 / 10 to VRA.


What is the valuation status of VERA BRADLEY INC (VRA) stock?

ChartMill assigns a valuation rating of 1 / 10 to VERA BRADLEY INC (VRA). This can be considered as Overvalued.


Can you provide the profitability details for VERA BRADLEY INC?

VERA BRADLEY INC (VRA) has a profitability rating of 1 / 10.


Can you provide the dividend sustainability for VRA stock?

The dividend rating of VERA BRADLEY INC (VRA) is 0 / 10 and the dividend payout ratio is 0%.